(0.29%) 5 114.61 points
(0.20%) 38 316 points
(0.32%) 15 979 points
(-1.01%) $83.00
(5.10%) $2.02
(0.11%) $2 349.80
(0.34%) $27.63
(3.66%) $955.85
(-0.20%) $0.933
(-0.29%) $10.99
(-0.49%) $0.796
(1.71%) $93.44
Live Chart Being Loaded With Signals
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders...
Stats | |
---|---|
Dagens volum | 15 080.00 |
Gjennomsnittsvolum | 24 942.00 |
Markedsverdi | 3.41M |
EPS | $0 ( 2024-03-27 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.220 |
ATR14 | $0.0520 (1.79%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-29 | Singh Vanila | Buy | 25 000 | Stock Option (right to buy) |
2024-01-29 | Shah Vinay | Buy | 112 000 | Stock Option (right to buy) |
2024-01-29 | Jambulingam Thani | Buy | 25 000 | Stock Option (right to buy) |
2024-01-29 | Mathias Sheila | Buy | 112 000 | Stock Option (right to buy) |
2024-01-29 | Dubin Michael F | Buy | 25 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
75.05 |
Last 71 transactions |
Buy: 2 396 200 | Sell: 387 701 |
Virpax Pharmaceuticals, Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
XBIO | 0.884 |
TRIP | 0.875 |
LTRPA | 0.868 |
SCWX | 0.852 |
SVAC | 0.851 |
GOODM | 0.845 |
MIND | 0.832 |
YTEN | 0.832 |
PRPO | 0.829 |
NVFY | 0.824 |
10 Mest negative korrelasjoner | |
---|---|
LWAC | -0.895 |
SRAC | -0.874 |
AFINO | -0.852 |
NETE | -0.845 |
RAVN | -0.839 |
AMRB | -0.82 |
LMRKN | -0.82 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Virpax Pharmaceuticals, Økonomi
Annual | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-12.97 |
FY | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-12.97 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-18.32 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-2.67 |
Financial Reports:
No articles found.
Virpax Pharmaceuticals,
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.